BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tang-Feldman Y, Mayo S, Silva Jr J, Cohen SH. Molecular analysis of Clostridium difficile strains isolated from 18 cases of recurrent clostridium difficile-associated diarrhea. J Clin Microbiol. 2003;41:3413-3414. [PMID: 12843107 DOI: 10.1128/JCM.41.7.3413-3414.2003] [Cited by in Crossref: 54] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Walk ST, Young VB. Emerging Insights into Antibiotic-Associated Diarrhea and Clostridium difficile Infection through the Lens of Microbial Ecology. Interdiscip Perspect Infect Dis 2008;2008:125081. [PMID: 19277109 DOI: 10.1155/2008/125081] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
2 Humphries RM, Linscott AJ. Practical Guidance for Clinical Microbiology Laboratories: Diagnosis of Bacterial Gastroenteritis. Clin Microbiol Rev 2015;28:3-31. [PMID: 25567220 DOI: 10.1128/CMR.00073-14] [Cited by in Crossref: 91] [Cited by in F6Publishing: 49] [Article Influence: 13.0] [Reference Citation Analysis]
3 Kelly BJ, Tebas P. Clinical Practice and Infrastructure Review of Fecal Microbiota Transplantation for Clostridium difficile Infection. Chest. 2018;153:266-277. [PMID: 28923757 DOI: 10.1016/j.chest.2017.09.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 4.2] [Reference Citation Analysis]
4 Hunt JJ, Ballard JD. Variations in virulence and molecular biology among emerging strains of Clostridium difficile. Microbiol Mol Biol Rev. 2013;77:567-581. [PMID: 24296572 DOI: 10.1128/mmbr.00017-13] [Cited by in Crossref: 62] [Cited by in F6Publishing: 45] [Article Influence: 7.8] [Reference Citation Analysis]
5 Song JH, Kim YS. Recurrent Clostridium difficile Infection: Risk Factors, Treatment, and Prevention. Gut Liver 2019;13:16-24. [PMID: 30400734 DOI: 10.5009/gnl18071] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
6 Figueroa I, Johnson S, Sambol SP, Goldstein EJ, Citron DM, Gerding DN. Relapse versus reinfection: recurrent Clostridium difficile infection following treatment with fidaxomicin or vancomycin. Clin Infect Dis. 2012;55 Suppl 2:S104-S109. [PMID: 22752857 DOI: 10.1093/cid/cis357] [Cited by in Crossref: 98] [Cited by in F6Publishing: 87] [Article Influence: 9.8] [Reference Citation Analysis]
7 Kamboj M, Khosa P, Kaltsas A, Babady NE, Son C, Sepkowitz KA. Relapse versus reinfection: surveillance of Clostridium difficile infection. Clin Infect Dis 2011;53:1003-6. [PMID: 21976462 DOI: 10.1093/cid/cir643] [Cited by in Crossref: 62] [Cited by in F6Publishing: 61] [Article Influence: 5.6] [Reference Citation Analysis]
8 Miner J, Gillan MM, Alex P, Centola M. Steroid-refractory ulcerative colitis treated with corticosteroids, metronidazole and vancomycin: a case report. BMC Gastroenterol 2005;5:3. [PMID: 15667650 DOI: 10.1186/1471-230X-5-3] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
9 Li D, Ren AM. Treatment of Clostridium difficile-associated diarrhea. Shijie Huaren Xiaohua Zazhi 2012; 20(6): 497-504 [DOI: 10.11569/wcjd.v20.i6.497] [Reference Citation Analysis]
10 Bakken JS, Borody T, Brandt LJ, Brill JV, Demarco DC, Franzos MA, Kelly C, Khoruts A, Louie T, Martinelli LP, Moore TA, Russell G, Surawicz C; Fecal Microbiota Transplantation Workgroup. Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol. 2011;9:1044-1049. [PMID: 21871249 DOI: 10.1016/j.cgh.2011.08.014] [Cited by in Crossref: 575] [Cited by in F6Publishing: 503] [Article Influence: 52.3] [Reference Citation Analysis]
11 Limmathurotsakul D, Chaowagul W, Chantratita N, Wuthiekanun V, Biaklang M, Tumapa S, White NJ, Day NP, Peacock SJ. A simple scoring system to differentiate between relapse and re-infection in patients with recurrent melioidosis. PLoS Negl Trop Dis 2008;2:e327. [PMID: 18958279 DOI: 10.1371/journal.pntd.0000327] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
12 Collins J, Auchtung JM. Control of Clostridium difficile Infection by Defined Microbial Communities. Microbiol Spectr 2017;5. [PMID: 28936948 DOI: 10.1128/microbiolspec.BAD-0009-2016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
13 Oka K, Osaki T, Hanawa T, Kurata S, Okazaki M, Manzoku T, Takahashi M, Tanaka M, Taguchi H, Watanabe T, Inamatsu T, Kamiya S. Molecular and microbiological characterization of Clostridium difficile isolates from single, relapse, and reinfection cases. J Clin Microbiol 2012;50:915-21. [PMID: 22205786 DOI: 10.1128/JCM.05588-11] [Cited by in Crossref: 61] [Cited by in F6Publishing: 25] [Article Influence: 6.1] [Reference Citation Analysis]
14 Johanesen PA, Mackin KE, Hutton ML, Awad MM, Larcombe S, Amy JM, Lyras D. Disruption of the Gut Microbiome: Clostridium difficile Infection and the Threat of Antibiotic Resistance. Genes (Basel) 2015;6:1347-60. [PMID: 26703737 DOI: 10.3390/genes6041347] [Cited by in Crossref: 53] [Cited by in F6Publishing: 42] [Article Influence: 7.6] [Reference Citation Analysis]
15 Sun X, Wang H, Zhang Y, Chen K, Davis B, Feng H. Mouse relapse model of Clostridium difficile infection. Infect Immun 2011;79:2856-64. [PMID: 21576341 DOI: 10.1128/IAI.01336-10] [Cited by in Crossref: 66] [Cited by in F6Publishing: 50] [Article Influence: 6.0] [Reference Citation Analysis]
16 Cojocariu C, Girleanu I, Trifan A, Olteanu A, Muzica CM, Huiban L, Chiriac S, Singeap AM, Cuciureanu T, Sfarti C, Stanciu C. Did the severe acute respiratory syndrome-coronavirus 2 pandemic cause an endemic Clostridium difficile infection? World J Clin Cases 2021; 9(33): 10180-10188 [PMID: 34904088 DOI: 10.12998/wjcc.v9.i33.10180] [Reference Citation Analysis]
17 Lin Z, Iqbal Z, Ortiz JF, Khan SA, Jahan N. Fecal Microbiota Transplantation in Recurrent Clostridium Difficile Infection: Is it Superior to Other Conventional Methods? Cureus 2020;12:e9653. [PMID: 32923252 DOI: 10.7759/cureus.9653] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Duarte-Chavez R, Wojda TR, Zanders TB, Geme B, Fioravanti G, Stawicki SP. Early Results of Fecal Microbial Transplantation Protocol Implementation at a Community-based University Hospital. J Glob Infect Dis 2018;10:47-57. [PMID: 29910564 DOI: 10.4103/jgid.jgid_145_17] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]